Are there biologic differences between male and female breast cancer explaining inferior outcome of men despite equal stage and treatment?!

Müller, A-C; Gani, C; Rehm, H M E; Eckert, F; Bamberg, M; Hehr, T; Weinmann, M

Müller, A-C; Gani, C; Rehm, H M E; Eckert, F; Bamberg, M; Hehr, T; Weinmann, M.

Affiliation

Müller AC; Department of Radiooncology, Eberhard-Karls-University Tübingen, Germany.

Strahlenther Onkol ; 188(9): 782-7, 2012 Sep.

Article in En | MEDLINE | ID: mdl-22847517

Subject(s)

Breast Neoplasms, Male/mortality; Breast Neoplasms, Male/therapy; Chemoradiotherapy, Adjuvant/mortality; Mastectomy/mortality; Adult; Aged; Aged, 80 and over; Female; Germany/epidemiology; Humans; Male; Middle Aged; Neoplasm Staging; Prevalence; Sex Distribution; Sex Factors; Survival Analysis; Survival Rate; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Breast Neoplasms, Male / Chemoradiotherapy, Adjuvant / Mastectomy Type of study: Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Strahlenther Onkol Year: 2012 Document type: Article

Search on Google

XML

PubMed Links